Llwytho...
A role for oncostatin M in inflammatory bowel disease
A new study identifies oncostatin M (OSM) as a potential biomarker and therapeutic target for anti-tumor necrosis factor (TNF)-refractory inflammatory bowel disease (IBD), and pinpoints mucosal stromal cells as key players in OSM-mediated inflammation.
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Nat Med |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527753/ https://ncbi.nlm.nih.gov/pubmed/28475567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4338 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|